Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits

Human Gene Therapy

Volumn 7, Issue 1, 1996, Pages 39-49

  Hughes, Steven D ^a   Rouy, Didier ^a,c   Navaratnam, Naveenan ^b   Scott, James ^b   Rubin, Edward M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CYTIDINE DEAMINASE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; MESSENGER RNA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; LIVER CELL; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; RABBIT; RNA EDITING; TRANSGENE; VIRUS RECOMBINANT;

EID: 0029874621     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.1-39     Document Type: Article

References (38)

1. BOSHART, M., WEBER, F., JAHN, G., DORSCH-HÄBER, K., FLECKENSTEIN, B., and SCHAFFNER, W. (1985). A very strong enchancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41, 521-530.
2. BOSTROM, K., GARCIA, Z., POKSAY, K.S., JOHNSON, D.F., LUSIS, A.J., and INNERARITY, T.L. (1990). Apolipoprotein B mRNA editing: direct determination of the edited base and occurrence in non-apolipoprotein B-producing cell lines. J. Biol. Chem. 265, 22445-22452.
3. 4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly. Proc. Natl. Acad. Sci. USA 90, 11643-11647.
4. CALLOW, M.J., STOLTZFUS, L.J., LAWN, R.M., and RUBIN, E.M. (1994). Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice. Proc. Natl. Acad. Sci. USA 91, 2130-2136.
5. CHAN, L. (1992). Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoproteins. J. Biol. Chem. 267, 25621-25624.
6. CHEN, S.-H., HABIB, G., YANG, C.-Y., GU, Z.-W., LEE, B.R., WENG, S.-A., SILBERMANN, S.R., CAI, S.-J., DESLYPERE, J.P., ROSSENEU, M., GOTTO, A.M., LI, W.-H., and CHAN, L. (1987). Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 238, 363-366.
7. CHIESA, G., JOHNSON, D.F., YAO, Z., INNERARITY, T.L., MAHLEY, R.W., YOUNG, S.G., HAMMER, R.H., and HOBBS, H.H. (1993). Expression of human apolipoprotein B100 in transgenic mice. J. Biol. Chem. 268, 23747-23750.
8. CORSETTI, J.P., STERRY, J.A., SPARKS, J.D., SPARKS, C.E., and WEINTRAUB, M. (1991). Effect of weight loss on serum lipoprotein(a) concentrations in an obese population. Clin. Chem. 37, 1191-1195.
9. DAVIDSON, N.O., POWELL, L.M., WALLIS, S.C., and SCOTT, J. (1988). Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA. J. Biol. Chem. 263, 13482-13485.
10. DAVIS, L.G., DIBNER, M.D., and BATTEY, J.F. (1986). Basic Methods in Molecular Biology. (Elsevier Science Publishing Co., New York) pp. 130-142.
11. DRISCOLL, D.M., WYNNE, J.K., WALLIS, S.C., and SCOTT, J. (1989). An in vitro system for the editing of apolipoprotein B mRNA. Cell 58, 519-525.
12. GIANNONI, F., BONEN, D.K., FUNASHASHl, T., HADJIAGAPIOU, C., BURANT, C.F., and DAVIDSON, N.O., (1994). Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48. J. Biol. Chem. 269, 5932-5936.
13. GREEVE, J., NAVARATNAM, N., and SCOTT, J. (1991). Characterization of the apolipoprotein B mRNA editing enzyme: no similarity to the proposed mechanism of RNA editing in kinetoplastid protozoa. Nucleic Acids Res. 19, 3569-3576.
14. GREEVE, J., ALTKEMPER, I., DIETERICH, J.-H., GRETEN H., and WINDLER, E. (1993). Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J. Lipid Res. 34, 1367-1383.
15. HARRIS, S.G., SABIO, I., MAYER, E., STEINBERG, M.F., BACKUS, J.W., SPARKS, J.D., SPARKS, C.E., and SMITH, H.C. (1993). Extract-specific heterogeneity in high-order complexes containing apolipoprotein B mRNA editing activity RNA-binding proteins. J. Biol. Chem. 268, 7382-7392.
16. HERZ, J., and GERARD, R.D. (1993). Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. USA 90, 2812-2816.
17. KNOTT, T.J., PEASE, R.J., POWELL, L.M., WALLIS, S.C., RALL JR., S.C., INNERARITY, T.L., BLACKHART, B., TAYLOR, W.H., MARCEL, Y., MILNE, R., JOHNSON, D., FULLER, M., LUSIS, A.J., MCCARTHY, B.J., MAHLEY, R.W., LEVY-WILSON, B., and SCOTT, J. (1986). Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature 323, 734-738.
18. KOZARSKY, K.F., MCKINLEY, D.R., AUSTIN, L.L., RAPER, S.E., STRATFORD-PERRICAUDET, L.D., and WILSON, J.M. (1994). In vivo correction of low density lipoprotein receptor deficiency in the watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 269, 13695-13702.
19. LAWN, R.M., WADE, D.P., HAMMER, R.E., CHIESA, G., VERSTUYFT, J.G., and RUBIN, E.M. (1992). Atherogenesis in transgenic mice expressing human apolipoprotein (a). Nature 360, 670-672.
20. LINTON, M.F., FARESE JR., R.V., CHIESA, G., GRASS, D.S., CHIN, P., HAMMER, R.E., HOBBS, H.H., and YOUNG, S.G. (1993). Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J. Clin. Invest. 92, 3029-3037.
21. MCCORMICK, S.P.A., LINTON, M.F., HOBBS, H.H., TAYLOR, S., CURTISS, L.K., and YOUNG, S.G. (1994). Expression of human apolipoprotein B90 in transgenic mice. J. Biol. Chem. 269, 24284-24289.
22. MENZEL, H.J., DIEPLINGER, H., LACKNERT, C., HOPPICHLER, F., LLOYD, J.K. MULLER, D.R., LABEUR, C., TALMUD, P.J., and UTERMANN, G. (1990). Abetalipoproteinemia with an ApoB100-lipoprotein(a) glycoprotein complex in plasma. J. Biol. Chem. 265, 981-986.
23. MILNE, R., THEOLIS JR., R., MAURICE, R., PEASE, R.J. WOECH, P.K., RASSART, E., FRUCHART, J.-C., SCOTT, J., and MARCEL, Y.L. (1989). The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B. J. Biol. Chem. 264, 19754-19760.
24. NAVARATNAM, N., MORRISON, J.R., BHATTACHARYA, S.D.P., FUNAHASHI, T., GIANNONI, F., TENG, B.-B., DAVIDSON, N.O., and SCOTT, J. (1993a). The p27 catalytic subunit of the apolipoprotein B mRNA editign enzyme is a cytidine deaminase. J. Biol. Chem. 264, 19754-19760.
25. NAVARATNAM, N., SHAH, R., PATEL, D., FAY, V., and SCOTT, J. (1993b). Apolipoprotein B mRNA editing is associated with UV crosslinking of proteins to the editing site. Proc. Natl. Acad. Sci. USA. 90, 222-226.
26. POWELL, L., WALLIS, S.C., PEASE, R.J., EDWARDS, Y.H., KNOTT, T.J., and SCOTT, J. (1987). A novel form of tissue-specific RNA processing produces apolipoprotein B48 in intestine. Cell 50, 831-840.
27. RHOADS, G.G., DAHLEN, G., BERG, K., MORTON, N.E., and DANNENBERG, A.L. (1986). Lp(a) lipoprotein as a risk factor for myocardial infarction. J. Am. Med. Assn. 256, 2540-2544.
28. SANDKAMP, M., FUNKE, H., SCHULTE, H., KOHLER, E., and ASSMANN, G. (1990). Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin. Chem. 36, 20-23.
29. SGOUTAS, D.S., and TUTEN, T. (1992). Effect of freezing and thawing of serum on the immunoassay of lipoprotein(a). Clin. Chem. 38, 1873-1877.
30. SMITH, H.C., KUO, S.R., BACKUS, J.W., HARRIS, S.G., SPARKS, C.E., and SPARKS, J.D. (1991). In vitro apolipoprotein B mRNA editing: Identification of a 27S editing complex. Proc. Natl. Acad. Sci. USA 88, 1489-1493.
31. TENG, B.-B., BLACK, D.D., and DAVIDSON, N.O. (1990). Apolipoprotein B messenger RNA editing is developmentally regulated in pig small intestine: Nucleotide comparison of apolipoprotein B editing regions in five species. Biochem. Biophys. Res. Commun. 173, 74-80.
32. TENG, B., BURANT, C.F., and DAVIDSON, N.O. (1993). Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260, 1816-1819.
33. TENG, B., BLUMENTHAL, S., FORTE, T., NAVARATNAM, N., SCOTT, J., GOTTO, A.J., and CHAN, L. (1994). Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. J. Biol. Chem. 269, 29395-29404.
34. THORNGATE, F.E., RAGHOW, R., WILCOX, H.G., WERNER, C.S., HEIMBERG, M., and ELAM, M.B. (1994). Insulin promotes the biosynthesis and secretion of apolipoportein B-48 by altering apolipoprotein B mRNA editing. Proc. Natl. Acad. Sci. USA 91, 5392-5396.
35. TIJSSEN, P. (1985). Practice and theory of enzyme immunoassays. Laboratory Techniques Biochem. Mol. Biol. 15, 345-347.
36. TOWBIN, H., STAEHELIN, T., and GORDON, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354.
37. WILLNOW, T.E., SHENG, Z., ISHIBASHI, S., and HERZ, J. (1994). Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science 264, 147-174.
38. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GÎNOZÎL, E., and WILSON, J.M. (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.